DUBLIN--(BUSINESS WIRE)--Aug 28, 2018--The "Radiotherapy - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

According to the report, the market accounted for $6.87 billion in 2017 and is expected to reach $13.39 billion by 2026 growing at a CAGR of 7.7% during the forecast period.

Factors such as increasing number of cancer patients and untapped market in some emerging countries are fuelling the market growth. However factors such as expensive treatments, adequate infrastructure and adequate skills and training are hampering the market growth.

By Geography, North America is expected to surpass other regions due to technological advancements, increasing healthcare expenditure, and high adoption of radiotherapy products owing to the increasing incidence of cancer followed by the Asia pacific region.

Products Covered

External Beam Radiotherapy Internal Beam Radiotherapy/Brachytherapy Systemic Radiotherapy

Types Covered

External Beam Radiotherapy Internal Beam Radiotherapy Systemic Radiotherapy

Applications Covered

External Beam Radiation Therapy Internal Beam Radiotherapy/Brachytherapy

End-Users Covered

Hospitals Cancer Research Institutes Ambulatory & Radiotherapy Centers

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Radiotherapy Market, By Product

5 Global Radiotherapy Market, By Type

7 Global Radiotherapy Market, By Application

8 Global Radiotherapy Market, By End-User

9 Global Radiotherapy Market, By Geography

10 Key Developments

11 Company Profiling

Accuray Incorporated C. R. Bard Inc. Siemens Elekta AB IBA (Ion Beam Applications SA) Isoray Medical Inc. Mevion Medical Systems Inc. Mitsubishi Electric Corporation Nordion Inc. Panacea Medical Technologies Pvt. Ltd. P-Cure Ltd. Pronova Solutions LLC Raysearch Laboratories Theragenics Corporation Varian Medical Systems Inc. Viewray Inc. ProTom International Inc. Covidien Ltd. Eckert & Ziegler BEBIG SA Provision Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/3pbv95/radiotherapy?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005381/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Nuclear Medicine and Radiopharmacology



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/28/2018 06:59 AM/DISC: 08/28/2018 06:59 AM